%0 Generic
%A Alten, R.
%A Lorenz, H-M.
%A Mariette, X.
%A Nuesslein, H.
%A Galeazzi, M.
%A Navarro, F.
%A Chartier, M.
%A Heitzmann, J.
%A Rauch, C.
%A Le Bars, M.
%T LESS THAN 5% OF REAL-LIFE PATIENTS WHO SWITCH FROM IV TO SC ABATACEPT IN REAL-WORLD CLINICAL PRACTICE SUBSEQUENTLY SWITCH BACK TO THE IV FORMULATION
%D 2017
%@ 0003-4967
%U https://hdl.handle.net/10668/27639
%K Subcutaneous formulation
%~